Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Soligenix (SNGX US)
Watchlist
7
Analysis
Health Care
•
United States
Soligenix, Inc. develops therapeutics and vaccines. The Company researches treatments for gastrointestinal Graft-versus-Host disease and cancer, and develops vaccines for military and civilian applications.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Soligenix
•
14 Aug 2024 03:00
•
Issuer-paid
SNGX: Phase 3 Trial of HyBryte in CTCL to Initiate in 2H24
On August 9, 2024, Soligenix, Inc. (SNGX) announced financial results for the second quarter of 2024 and provided a business update. The company...
Zacks Small Cap Research
Follow
129 Views
Share
bullish
•
Soligenix
•
14 Aug 2024 00:00
•
Issuer-paid
SNGX: Phase 3 Trial of HyBryte in CTCL to Initiate in 2H24
On August 9, 2024, Soligenix, Inc. (SNGX) announced financial results for the second quarter of 2024 and provided a business update. The company...
Zacks Small Cap Research
Follow
142 Views
Share
bullish
•
Soligenix
•
11 Jul 2024 01:00
•
Issuer-paid
SNGX: Positive Interim Results for HyBryte in Investigator-Initiated Study in CTCL Raising Valuation to 35
On July 9, 2024, Soligenix, Inc. (SNGX) announced positive interim results for HyBryte in an open-label, investigator-initiated study in patients...
Zacks Small Cap Research
Follow
185 Views
Share
bullish
•
Soligenix
•
15 Jun 2024 00:00
•
Issuer-paid
SNGX: Valuation Change Based on Reverse Split
On June 6, 2024, Soligenix, Inc. (SNGX) enacted a reverse stock split at a ratio of 1 post-split share for every 16 pre-split shares. Our...
Zacks Small Cap Research
Follow
140 Views
Share
bullish
•
Soligenix
•
15 May 2024 20:00
•
Issuer-paid
SNGX: Second Confirmatory Phase 3 Trial of HyBryte in CTCL to Initiate Before End of 2024
On May 10, 2024, Soligenix, Inc. (SNGX) announced financial results for the first quarter of 2024 and provided a business update. The company...
Zacks Small Cap Research
Follow
144 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x